We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.77B
AUM Growth
+$297M
Cap. Flow
+$195M
Cap. Flow %
11%
Top 10 Hldgs %
25.89%
Holding
186
New
46
Increased
63
Reduced
28
Closed
46

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$50.4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$40.6M
3
CNC icon
Centene
CNC
+$33.7M
4
CLVT icon
Clarivate
CLVT
+$27.5M
5
BAX icon
Baxter International
BAX
+$23.8M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$35.3M
2
CRM icon
Salesforce
CRM
+$28.3M
3
FLEX icon
Flex
FLEX
+$21.2M
4
IPGP icon
IPG Photonics
IPGP
+$18.1M
5
LYFT icon
Lyft
LYFT
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 14.56%
3 Communication Services 14.3%
4 Consumer Discretionary 11.94%
5 Industrials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROVR
51
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$11.3M 0.64%
2,499,192
+39,586
+2% +$160K
LAZ icon
52
Lazard
LAZ
$4.16B
$11.2M 0.63%
+339,048
New +$12.5M
HRT
53
DELISTED
HireRight Holdings Corporation
HRT
$11M 0.62%
1,034,507
+23,140
+2% +$261K
CPA icon
54
Copa Holdings
CPA
$5.58B
$10.7M 0.61%
+116,080
New +$10.5M
FLEX icon
55
Flex
FLEX
$44.2B
$10.3M 0.58%
596,262
-1,226,440
-67% -$21.2M
TTE icon
56
TotalEnergies
TTE
$195B
$10.3M 0.58%
173,642
+3,826
+2% +$235K
EQC
57
DELISTED
Equity Commonwealth
EQC
$10.2M 0.58%
+494,679
New +$11.5M
HII icon
58
Huntington Ingalls Industries
HII
$13B
$10.2M 0.58%
+49,451
New +$10.7M
CLS icon
59
Celestica
CLS
$36.2B
$9.72M 0.55%
753,222
-699,068
-48% -$8.94M
CXW icon
60
CoreCivic
CXW
$3.26B
$9.58M 0.54%
1,041,755
+189,987
+22% +$1.95M
APP icon
61
CALL
Applovin
APP
$113B
$9.45M 0.53%
600,000
-96,900
-14% -$1.27M
MG icon
62
Mistras Group
MG
$502M
$8.37M 0.47%
1,234,366
+18,604
+2% +$102K
MUR icon
63
Murphy Oil
MUR
$5.09B
$8.16M 0.46%
+220,558
New +$8.81M
FDX icon
64
FedEx
FDX
$76.9B
$8.1M 0.46%
35,468
-8,309
-19% -$1.69M
LRN icon
65
Stride
LRN
$3.33B
$7.93M 0.45%
201,932
-307,471
-60% -$12.1M
CVS icon
66
CVS Health
CVS
$122B
$7.92M 0.45%
+106,643
New +$8.94M
HAS icon
67
Hasbro
HAS
$13.3B
$7.91M 0.45%
+147,353
New +$8.42M
PLCE icon
68
Children's Place
PLCE
$58.3M
$7.84M 0.44%
194,845
-45,685
-19% -$1.88M
LUV icon
69
Southwest Airlines
LUV
$22B
$7.81M 0.44%
239,910
+70,859
+42% +$2.41M
AMK
70
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$7.81M 0.44%
248,177
-104,281
-30% -$2.92M
UFI icon
71
UNIFI
UFI
$129M
$7.8M 0.44%
954,148
+9,858
+1% +$87.9K
RJF icon
72
Raymond James Financial
RJF
$34.5B
$7.58M 0.43%
+81,277
New +$8.61M
INTC icon
73
Intel
INTC
$492B
$7.57M 0.43%
231,829
-257,120
-53% -$7.28M
ST icon
74
Sensata Technologies
ST
$6.66B
$7.53M 0.43%
150,532
+3,730
+3% +$180K
NWL icon
75
Newell Brands
NWL
$2.51B
$7.3M 0.41%
587,126
+14,823
+3% +$209K
1 2
3
4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Invenomic Capital Management held 186 positions worth $1.77B, up 20% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management deployed $195M of net new capital in Q1 2023, opening 46 new positions and adding to 63 existing holdings. Its largest new stake was Corpay: 248,424 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $35.3M trimmed.

  • Invenomic Capital Management's largest Q1 2023 buy was Corpay: 248,424 shares worth $52.4M.
  • Invenomic Capital Management added most to Centene in Q1 2023, an estimated $33.7M increase.
  • Invenomic Capital Management's biggest Q1 2023 reduction was Applovin, cutting an estimated $35.3M.
  • Invenomic Capital Management fully exited Salesforce in Q1 2023, selling an estimated $28.3M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $1.77B portfolio in Q1 2023.
  • Invenomic Capital Management opened 46 new positions and closed 46 in Q1 2023.
  • Invenomic Capital Management's portfolio value rose 20% quarter-over-quarter to $1.77B.

Based on Invenomic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.